Publications

prescription drugs

November 18th, 2022

prescription drugs

November 18th, 2022

Regence Leads the Industry in Biosimilar Adoption

Greater adoption of biosimilars is one path to driving down drug costs in the United States. Effectively increasing uptake will require collaboration between all segments of the health care system. Regence health plans are leading the industry in biosimilars utilization with 95 percent adoption, thus reducing specialty drug spend by $30 million since 2019.

Laura Sconyers

4 min read

Topics

care at home

June 22nd, 2022

care at home

June 22nd, 2022

Moving Cancer Care into the Home with the Huntsman at Home™ Program

Continuing our Care at Home Series, we interviewed American Scientist, Co-Leader of Cancer Control and Population Sciences at the Huntsman Cancer Institute and Distinguished Professor in the College of Nursing for the University of Utah, Dr. Kathi Mooney.

Dr. Kathi Mooney,

Vince Porter

5 min read
care at home

June 8th, 2022

care at home

June 8th, 2022

Home-Based Care: What Does the Future Hold?

One hundred years ago, it was common for doctors to visit patients at home. Over time, house calls and other forms of home-based care became less popular as patients increasingly received care in hospitals and other institutional settings. While most care now takes place in medical facilities, in recent years there has been a resurgence in home-based care as a convenient and cost-effective way to provide treatment for patients.

Vince Porter

5 min read
health policy

May 31st, 2022

health policy

May 31st, 2022

Welcome to the Regence Health Policy Center

The Regence Health Policy Center will build on Cambia Grove's connections and shared knowledge to advance policies that address and solve the emerging challenges facing our health care system.

Vince Porter

2 min read